Christopher Wale
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Global Cancer Incidence and Screening
Papers in
-
- Breast Cancer Treatment Studies 4
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- Mitch Dowsett (4 shared papers)Anthony Howell (3 shared papers)Jack Cuzick (3 shared papers)John Forbes (3 shared papers)Janine Salter (3 shared papers)Emma M. Quinn (2 shared papers)Aman U. Buzdar (2 shared papers)Lila Zabaglo (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Epidemiology & Community Health (2 papers)The Lancet Oncology (1 paper)Cancer Research (1 paper)PubMed (1 paper)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Christopher Wale
8 papers receiving 1.5k citations
Christopher Wale's Hit Papers
Peers
Comparison fields: 5 of 81
- Cancer Research 933
- Oncology 528
- Pathology and Forensic Medicine 140
- Genetics 194
- Pulmonary and Respiratory Medicine 173
Countries citing papers authored by Christopher Wale
This map shows the geographic impact of Christopher Wale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Wale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Wale more than expected).
Fields of papers citing papers by Christopher Wale
This network shows the impact of papers produced by Christopher Wale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Wale. The network helps show where Christopher Wale may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Wale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study Hit paper breakdown → | 2010 | 570 |
| 2 | Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer Hit paper breakdown → | 2011 | 569 |
| 3 | 2015 | 143 | |
| 4 | 1991 | 108 | |
| 5 | Symptoms perceived and recorded by patients. | 1976 | 66 |
| 6 | 2009 | 56 | |
| 7 | 2010 | 12 | |
| 8 | 1977 | 9 |
About Christopher Wale
Christopher Wale is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Health and General Health Professions, having authored 8 papers that have together received 1.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (4 papers), Advanced Breast Cancer Therapies (3 papers), Estrogen and related hormone effects (1 paper), Health disparities and outcomes (1 paper), Healthcare Policy and Management (1 paper), Global Cancer Incidence and Screening (1 paper), Cancer Treatment and Pharmacology (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Cancer Research (933 citations), Oncology (528 citations), Pathology and Forensic Medicine (140 citations), Genetics (194 citations) and Pulmonary and Respiratory Medicine (173 citations). Christopher Wale has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Mitch Dowsett, Anthony Howell, Jack Cuzick, John Forbes, Janine Salter, Emma M. Quinn, Aman U. Buzdar, Lila Zabaglo, Andrew R. Green and Elizabeth Mallon. Their work appears in journals such as Journal of Clinical Oncology, Journal of Epidemiology & Community Health, The Lancet Oncology, Cancer Research and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.